ERA7 STRENGHTEN ITS TEAM WITH DR. JAVIER VELASCO AS BUSINESS DEVELOPMENT MANAGER
Era7, a company founded by researchers Dr. Raquel Tobes and Dr. Eduardo Pareja and that has been focused for more than 10 years in the field of "Next Generation Sequencing" (NGS) with a special dedication to the field of bacterial genomics and the analysis of microbiomes, has incorporated Dr. Javier Velasco as Business Development Manager.
Javier Velasco holds a PhD in Industrial Biotechnology and accumulates more than 10 years of experience in the management of biotechnology companies as he has been CEO of two biotech companies (Neuron Bio and Neol Bio). Previously he was in charge of the Biotechnology Department of Puleva Biotech (now Biosearch) and before that he was a researcher at GlaxoSmithKline and Antibióticos SA.
Dr. Velasco is co-author of more than 30 scientific articles and chapters in books and is co-inventor in 17 families of patents related to biotechnological processes and products.
He has been a member of the Board of Directors of ASEBIO (Spanish Association of Bioindustries) and is currently part of the Board of the Spanish Observatory of Bioeconomy.
We are sure that the incorporation of Javier Velasco to our team will be key in the opening of markets and the internationalization of platforms and services offered by Era7. His broad experience in different areas of management and biotechnology research applied to key sectors such as Human Health, Agri-Food and Biofuels, among others perfectly complements the technical capabilities of Era7
Said Dr. Eduardo Pareja, CEO of Era7 Bioinformatics.
Javier Velasco has indicated:
I am very excited about this new phase in a company I've known since its inception, which has a vast technological background and a huge growth potential. I hope I can contribute to this from my new position